All News #Library
Biotech
Triveni Initiates Global Phase 2 Study Of Triv-509 In Atopic
23 Sep 2025 //
PR NEWSWIRE
Triveni Begins TRIV-509 Trial in Atopic Dermatitis
21 May 2025 //
PR NEWSWIRE
Triveni Bio Raises $115M For Immunological Disorder Therapies
02 Oct 2024 //
PR NEWSWIRE
I&I biotech Triveni raises $115M for preclinical antibodies
02 Oct 2024 //
FIERCE BIOTECH

Market Place
Sourcing Support